Advances in Molecular Pathology, 2024

<i>Advances in Molecular Pathology </i>reviews the year&rsquo;s most important findings and updates within the field in order to provide practitioners with the current clinical information they need to improve patient outcomes. A distinguished editorial board <b>identifies key areas of major progress</b> <b>and controversy</b> and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in molecular pathology inform and enhance clinical practice by <b>bringing concepts to a clinical level and exploring their everyday impact on patient care</b>.<ul><li>Contains <b>24 articles</b> on such topics as chronic myelomonocytic leukemia; antimicrobial resistance marker detection and clinical interpretation/limitations; DPYD and the congenital DPD deficiency; FHIR genomic operations; AI in genomics; clinical value of molecular LDTs; and more.</li><li>Provides in-depth, <b>clinical reviews in molecular pathology</b>, providing actionable insights for clinical practice.</li><li>Presents the <b>latest information in the field</b> under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.</li></ul>